Please login to the form below

Not currently logged in
From: Research

Novartis steps up its efforts in immuno-oncology

Novartis buildingDedicated R&D unit created alongside $750m collaboration with Aduro

From: Sales

Eisai’s thyroid cancer drug Lenvima nears EU approval

EISAIPositive recommendation by the CHMP could see the orphan drug used in Europe within three months

From: Healthcare

UK to pay for GSK’s MenB vaccine after year’s delay

GSK - logo on buildingBritish firm says the deal offers ‘fair value’ to the NHS

From: Research

Open health data network launches in US

'Open Humans’ wants people to share health information to accelerate medical breakthroughs

The end of hepatitis C?

Next-gen hep C therapies may see the disease's global elimination - but treament access must be stepped up dramatically

darwins medicine

Under pressure

Life science companies must prioritise their response to market changes

Leo Pharma sets out its social media principles

Also expands its use of Twitter with two new accounts

Leo Pharma corporate Twitter account

Insmed appoints FDA's Dr Eugene Sullivan

He joins the US biopharmaceutical firm as its chief medical officer


New firm, new thinking

AbbVie’s UK general manager Matt Regan on creating an evolved culture from Abbott

Ipsen's Marc de Garidel to chair IMI's governing board

He takes over from former UCB CEO Roch Doliveux

Ipsen Marc de Garidel IMI Innovative Medicines Initiative

UCB plans epilepsy 'hackathon' to develop digital tools

Aims to attract developers, designers and digital experts to Hack Epilepsy

UCB Hack Epilepsy hackathon

Featured jobs

Subscribe to our email news alerts


Add my company
11 London

Fast-acting communications agency creating content for anything to do with health, in any medium – digital or offline. We develop...

Latest intelligence

Capturing "in-the-moment" patient and physician insights
Utilising the benefits of mobile technology...
Webinar: Observational Research
Presenting a window on the world of your customer...
Webinar: The Brazil Conundrum
Conducting research in one of the world's largest pharma markets...